Search

Author/Creator Bajorin, Dean F

1. Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial. (26th October 2022)

Authors:
Tomita, Yoshihiko; Kobayashi, Ko; Kimura, Go; Oya, Mototsugu; Uemura, Hirotsugu; Nishiyama, Hiroyuki; Galsky, Matthew D; Nasroulah, Federico; Collette, Sandra; Broughton, Edward; Ünsal-Kaçmaz, Keziban; Kamisuki, Yukinori; Bajorin, Dean F
Journal:
Japanese journal of clinical oncology
Issue:
Volume 53:Number 1(2023)
Page Start:
16
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial. Issue 10064 (7th January 2017)

Authors:
Balar, Arjun V; Galsky, Matthew D; Rosenberg, Jonathan E; Powles, Thomas; Petrylak, Daniel P; Bellmunt, Joaquim; Loriot, Yohann; Necchi, Andrea; Hoffman-Censits, Jean; Perez-Gracia, Jose Luis; Dawson, Nancy A; van der Heijden, Michiel S; Dreicer, Robert; Srinivas, Sandy; Retz, Margitta M; Joseph,...
Journal:
Lancet
Issue:
Volume 389:Issue 10064(2017)
Page Start:
67
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study. Issue 7 (July 2021)

Authors:
Balar, Arjun V; Kamat, Ashish M; Kulkarni, Girish S; Uchio, Edward M; Boormans, Joost L; Roumiguié, Mathieu; Krieger, Laurence E M; Singer, Eric A; Bajorin, Dean F; Grivas, Petros; Seo, Ho Kyung; Nishiyama, Hiroyuki; Konety, Badrinath R; Li, Haojie; Nam, Kijoeng; Kapadia, Ekta; Frenkl, Tara; de W...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 7(2021)
Page Start:
919
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗